I-Mab Biopharma
IMAB
$1.76
Share price
0.00%
Change (1 day)
-40.17%
Change (1 year)
Categories
I-Mab Biopharma (IMAB) - Total assets
Total assets on the balance sheet as of June 2023 : $0.48 B
According to I-Mab Biopharma's latest financial reports the company's total assets are $0.48 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
I-Mab Biopharma - Total assets on balance sheet (from 2018 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.59 B | -32.81% |
| 2021-12-31 | $0.87 B | -9.48% |
| 2020-12-31 | $0.97 B | 290.42% |
| 2019-12-31 | $0.24 B | -28% |
| 2018-12-31 | $0.34 B | 119.2% |
| 2017-12-31 | $0.15 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $2.01 B | 315.43% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $22.68 M | -95.32% | 🇺🇸 USA |